GenMark Diagnostics (GNMK) Gains FDA 510(k) for ePlex Blood Culture Identification Gram-Negative Panel
Tweet Send to a Friend
GenMark Diagnostics, Inc. (NASDAQ: GNMK) received FDA 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for its ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
